131 related articles for article (PubMed ID: 11975595)
1. Synthesis of an influenza neuraminidase inhibitor intermediate via a highly diastereoselective coupling reaction.
Barnes DM; McLaughlin MA; Oie T; Rasmussen MW; Stewart KD; Wittenberger SJ
Org Lett; 2002 May; 4(9):1427-30. PubMed ID: 11975595
[TBL] [Abstract][Full Text] [Related]
2. [C+NC+CC] coupling-enabled synthesis of influenza neuramidase inhibitor A-315675.
Garner P; Weerasinghe L; Youngs WJ; Wright B; Wilson D; Jacobs D
Org Lett; 2012 Mar; 14(5):1326-9. PubMed ID: 22339284
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of A-315675: a potent inhibitor of influenza neuraminidase.
Hanessian S; Bayrakdarian M; Luo X
J Am Chem Soc; 2002 May; 124(17):4716-21. PubMed ID: 11971721
[TBL] [Abstract][Full Text] [Related]
4. Chiral iminoesters derived from D-glyceraldehyde in [3 + 2] cycloaddition reactions. Asymmetric synthesis of a key intermediate in the synthesis of neuramidinase inhibitors.
Gálvez JA; Díaz-de-Villegas MD; Alías M; Badorrey R
J Org Chem; 2013 Nov; 78(22):11404-13. PubMed ID: 24143968
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective synthesis of antiinfluenza compound A-315675.
DeGoey DA; Chen HJ; Flosi WJ; Grampovnik DJ; Yeung CM; Klein LL; Kempf DJ
J Org Chem; 2002 Aug; 67(16):5445-53. PubMed ID: 12153241
[TBL] [Abstract][Full Text] [Related]
7. 4-(Acetylamino)-3-hydroxy-5-nitrobenzoic acid.
Jedrzejas MJ; Luo M; Singh S; Brouillette WJ; Air GM
Acta Crystallogr C; 1995 Sep; 51 ( Pt 9)():1910-2. PubMed ID: 7576370
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.
Wang GT; Chen Y; Wang S; Gentles R; Sowin T; Kati W; Muchmore S; Giranda V; Stewart K; Sham H; Kempf D; Laver WG
J Med Chem; 2001 Apr; 44(8):1192-201. PubMed ID: 11312919
[TBL] [Abstract][Full Text] [Related]
9. A QSAR study on influenza neuraminidase inhibitors.
Verma RP; Hansch C
Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of influenza neuraminidase inhibitors.
Abdel-Magid AF; Maryanoff CA; Mehrman SJ
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):776-91. PubMed ID: 11899618
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.
Wang GT; Wang S; Gentles R; Sowin T; Maring CJ; Kempf DJ; Kati WM; Stoll V; Stewart KD; Laver G
Bioorg Med Chem Lett; 2005 Jan; 15(1):125-8. PubMed ID: 15582424
[TBL] [Abstract][Full Text] [Related]
12. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
Stoll V; Stewart KD; Maring CJ; Muchmore S; Giranda V; Gu YG; Wang G; Chen Y; Sun M; Zhao C; Kennedy AL; Madigan DL; Xu Y; Saldivar A; Kati W; Laver G; Sowin T; Sham HL; Greer J; Kempf D
Biochemistry; 2003 Jan; 42(3):718-27. PubMed ID: 12534284
[TBL] [Abstract][Full Text] [Related]
13. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
Sun J; Mei H
Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
[TBL] [Abstract][Full Text] [Related]
14. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
Lew W; Wu H; Mendel DB; Escarpe PA; Chen X; Laver WG; Graves BJ; Kim CU
Bioorg Med Chem Lett; 1998 Dec; 8(23):3321-4. PubMed ID: 9873727
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors.
Zhang L; Williams MA; Mendel DB; Escarpe PA; Chen X; Wang KY; Graves BJ; Lawton G; Kim CU
Bioorg Med Chem Lett; 1999 Jul; 9(13):1751-6. PubMed ID: 10406636
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 6-acetamido-5-amino- and -5-guanidino-3, 4-dehydro-N-(2-ethylbutyryl)- 3-piperidinecarboxylic acids related to zanamivir and oseltamivir, inhibitors of influenza virus neuraminidases.
Shitara E; Nishimura Y; Nerome K; Hiramoto Y; Takeuchi T
Org Lett; 2000 Nov; 2(24):3837-40. PubMed ID: 11101432
[TBL] [Abstract][Full Text] [Related]
18. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
[No Abstract] [Full Text] [Related]
19. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.
Brouillette WJ; Atigadda VR; Luo M; Air GM; Babu YS; Bantia S
Bioorg Med Chem Lett; 1999 Jul; 9(14):1901-6. PubMed ID: 10450950
[TBL] [Abstract][Full Text] [Related]
20. Novel linear polymers bearing thiosialosides as pendant-type epitopes for influenza neuraminidase inhibitors.
Matsuoka K; Takita C; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Hatano K; Terunuma D
Bioorg Med Chem Lett; 2007 Jul; 17(14):3826-30. PubMed ID: 17524642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
